PRPH logo

ProPhase Labs, Inc. (PRPH)

Profile

Full Name

ProPhase Labs, Inc.

Ticker

NASDAQ: PRPH

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

April 4, 1994

Indexes

Not included

Website

https://www.prophaselabs.com

Employees

96

Key Details

Price

$0.11(0.00%)

Market Cap

Last Dividend

$0.30

TTM Dividend Yield

-

Annual Revenue

$6.77M(-80.65% YoY)

Annual EPS

-$2.61(-167.38% YoY)

PE Ratio

-

Next earnings date

Mar 30, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.11
    PRPH price is $0.11

    30-Day Relative Volume

    1.28
    PRPH 30-day relative volume is 1.28

    Price Performance

    Price Most Recent Change

    0%
    PRPH price has remained unchanged on Dec 18, 2025

    Price YTD Change

    -85.53%
    PRPH price is down -85.53% since January 1st

    Price 1-Year Change

    -83.08%
    PRPH price is down -83.08% year-on-year

    Price 3-Year Change

    -98.92%
    PRPH price is down -98.92% over the past 3 years

    Price Range

    Price All-Time High

    $23.00
    PRPH price is currently -99.52% below its historical high of $23.00

    Price 3-Year Low

    $0.10
    PRPH price is currently +10.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $5.08M
    PRPH market cap is $5.08 million

    Market Cap 3-Year Change

    -96.93%
    PRPH market cap is down -96.93% over the past 3 years

    Market Cap All-Time High

    $269.49M
    PRPH market cap is currently -98.12% below its historical high of $269.49 million

    Market Cap Sector Percentile

    11.45%
    PRPH market cap is higher than 11.45% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +93.43%
    PRPH shares outstanding is up +93.43% year-on-year

    Shares Outstanding 3-Year Change

    +183.69%
    PRPH shares outstanding is up +183.69% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.35
    PRPH beta is 2.35

    200-day SMA

    $0.35
    PRPH price is currently -68.79% below its 200-day simple moving average

    50-day SMA

    $0.28
    PRPH price is currently -61.27% below its 50-day simple moving average

    14-Day RSI

    28.35
    PRPH 14-day relative strength index is 28.35

    Volume

    1.28
    PRPH 30-day relative volume is 1.28

    ATR

    $0.03
    PRPH average true range is $0.03

    10-day Historical Volatility

    147.62%
    PRPH 10-day historical volatility is 147.62%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.30
    PRPH last dividend was $0.30 per share, with an ex-dividend date of May 24, 2022

    Next Dividend

    -
    PRPH next dividend has not yet been announced

    Dividend per share

    Dividend Per Share

    -
    PRPH annual dividend per share value is unknown

    Dividend Per Share Sector Percentile

    -
    PRPH annual dividend per share is unknown

    Dividend Per Share 1-Year Change

    -
    PRPH annual dividend per share 1-year change is unknown

    Dividend Per Share 3-Year Change

    -
    PRPH annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend Yield

    -
    PRPH annual dividend yield value is unknown

    Dividend Yield Sector Percentile

    -
    PRPH annual dividend yield is unknown

    Other

    Payout Ratio

    0.00%
    PRPH annual payout ratio is 0.00%

    Dividends Paid

    $0.00
    PRPH annual dividends paid is $0.00

    Free Cash Flow

    -$18.44M
    PRPH annual free cash flow is -$18.44 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $6.77M
    PRPH annual revenue is $6.77 million

    Revenue Analysts Estimate

    -
    PRPH annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    -80.65%
    PRPH annual revenue is down -80.65% year-on-year

    Revenue Sector Percentile

    45.31%
    PRPH annual revenue is higher than 45.31% of companies in Healthcare sector

    EPS

    EPS

    -$2.61
    PRPH annual earnings per share is -$2.61

    EPS Analysts Estimate

    -
    PRPH annual earnings per share consensus analysts' forecast is unknown

    EPS 1-Year Change

    -167.38%
    PRPH annual earnings per share is down -167.38% year-on-year

    EPS Sector Percentile

    33.76%
    PRPH annual earnings per share is higher than 33.76% of companies in Healthcare sector

    Profit

    Gross Profit

    -$150.00K
    PRPH annual gross profit is -$150.00 thousand

    Gross Margin

    -2.22%
    PRPH annual gross profit margin is -2.22%

    Operating Profit

    -$38.63M
    PRPH annual operating income is -$38.63 million

    Operating Margin

    -672.81%
    PRPH annual operating profit margin is -672.81%

    Net Income

    -$49.52M
    PRPH annual net profit is -$49.52 million

    Net Margin

    -731.54%
    PRPH annual net profit margin is -731.54%

    Expenses

    Total Expenses

    $56.30M
    PRPH annual total expenses is $56.30 million

    Operating Expenses

    $38.48M
    PRPH annual total operating expenses is $38.48 million

    Cost Of Goods Sold

    $6.92M
    PRPH annual cost of goods sold is $6.92 million

    Selling, General & Administrative Expenses

    $0.00
    PRPH annual SG&A is $0.00

    Depreciation & Amortization

    $6.64M
    PRPH annual D&A is $6.64 million

    Interest Expense

    $0.00
    PRPH annual interest expense is $0.00

    Income Tax

    $7.20M
    PRPH annual income tax is $7.20 million

    EBIT & EBITDA

    EBIT

    -$38.63M
    PRPH annual earnings before interest & taxes is -$38.63 million

    EBITDA

    -$31.98M
    PRPH annual EBITDA is -$31.98 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $63.20M
    PRPH annual total assets is $63.20 million

    Non Current Assets

    $32.56M
    PRPH annual long term assets is $32.56 million

    Current Assets

    $30.64M
    PRPH annual total current assets is $30.64 million

    Cash and Cash Equivalents

    $678.00K
    PRPH annual cash & cash equivalents is $678.00 thousand

    Accounts Receivable

    $20.06M
    PRPH annual accounts receivable is $20.06 million

    Inventory

    $1.14M
    PRPH annual inventory is $1.14 million

    Liabilities

    Total Liabilities

    $55.85M
    PRPH annual total liabilities is $55.85 million

    Long Term Liabilities

    $23.71M
    PRPH annual total long term liabilities is $23.71 million

    Current Liabilities

    $32.13M
    PRPH annual current liabilities is $32.13 million

    Accounts Payable

    $13.72M
    PRPH annual accounts payable is $13.72 million

    Debt

    Total Debt

    $24.57M
    PRPH annual total debt is $24.57 million

    Total Debt 1-Year Change

    +33.14%
    PRPH annual total debt is up +33.14% year-on-year

    Long Term Debt

    $18.00M
    PRPH annual long term debt is $18.00 million

    Short Term Debt

    $6.57M
    PRPH annual short term debt is $6.57 million

    Equity & Capital

    Shareholders Equity

    $7.35M
    PRPH annual stockholders equity is $7.35 million

    Book Value

    $7.35M
    PRPH annual book value is $7.35 million

    Retained Earnings

    -$58.39M
    PRPH annual retained earnings is -$58.39 million

    Working Capital

    -$1.50M
    PRPH annual working capital is -$1.50 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$17.54M
    PRPH annual cash from operations is -$17.54 million

    Cash From Operations 1-Year Change

    -47.53%
    PRPH annual cash from operations is down -47.53% year-on-year

    Cash From Investing

    $2.42M
    PRPH annual cash from investing is $2.42 million

    Cash From Investing 1-Year Change

    +276.92%
    PRPH annual cash from investing is up +276.92% year-on-year

    Cash From Financing

    $14.19M
    PRPH annual cash from financing is $14.19 million

    Cash From Financing 1-Year Change

    +146.4%
    PRPH annual cash from financing is up +146.4% year-on-year

    CAPEX

    CAPEX

    $906.00K
    PRPH annual capital expenditures is $906.00 thousand

    CAPEX 1-Year Change

    -56.53%
    PRPH annual capital expenditures is down -56.53% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$18.44M
    PRPH annual free cash flow is -$18.44 million

    Free Cash Flow 1-Year Change

    -32.01%
    PRPH annual free cash flow is down -32.01% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -2.22%
    PRPH annual gross profit margin is -2.22%

    Operating Margin

    -672.81%
    PRPH annual operating profit margin is -672.81%

    Net Margin

    -731.54%
    PRPH annual net profit margin is -731.54%

    ROA & ROE

    ROA

    -63.85%
    PRPH annual return on assets is -63.85%

    ROE

    -174.58%
    PRPH annual return on equity is -174.58%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    PRPH price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    PRPH price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    0.74
    PRPH price to book ratio is 0.74

    PB Ratio Sector Percentile

    30.82%
    PRPH price to book ratio is higher than 30.82% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    1.43
    PRPH price to sales ratio is 1.43

    PS Ratio Sector Percentile

    28.2%
    PRPH price to sales ratio is higher than 28.2% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $12.36M
    PRPH enterprise value is $12.36 million

    Enterprise Value Sector Percentile

    23.29%
    PRPH enterprise value is higher than 23.29% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.80
    PRPH EV/EBITDA is -1.80

    EV/EBITDA Sector Percentile

    39.42%
    PRPH EV/EBITDA is higher than 39.42% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    0.95
    PRPH annual current ratio is 0.95

    Quick Ratio

    0.92
    PRPH annual quick ratio is 0.92

    Leverage

    Debt To Equity

    3.34
    PRPH annual debt to equity ratio is 3.34

    Interest Coverage Ratio

    -
    PRPH annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    2
    PRPH piotroski f-score is 2

    Altman Z-Score

    -3.18
    PRPH altman z-score is -3.18

    Analyst ratings

    Recent major analysts updates

    Feb 21, 24 HC Wainwright & Co.
    Buy
    Nov 10, 23 HC Wainwright & Co.
    Buy
    Aug 14, 23 HC Wainwright & Co.
    Buy
    Jun 2, 23 HC Wainwright & Co.
    Buy
    May 12, 23 HC Wainwright & Co.
    Buy
    Mar 8, 23 HC Wainwright & Co.
    Buy
    Feb 23, 23 HC Wainwright & Co.
    Buy
    Feb 16, 23 HC Wainwright & Co.
    Buy
    Feb 7, 23 HC Wainwright & Co.
    Buy
    Nov 11, 22 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with PRPH included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for ProPhase Labs, Inc.?
    • Does ProPhase Labs, Inc. pay dividends?
    • What sector is ProPhase Labs, Inc. in?
    • What industry is ProPhase Labs, Inc. in?
    • What country is ProPhase Labs, Inc. based in?
    • When did ProPhase Labs, Inc. go public?
    • Is ProPhase Labs, Inc. in the S&P 500?
    • Is ProPhase Labs, Inc. in the NASDAQ 100?
    • Is ProPhase Labs, Inc. in the Dow Jones?
    • When was ProPhase Labs, Inc.'s last earnings report?
    • When does ProPhase Labs, Inc. report earnings?

    What is the ticker symbol for ProPhase Labs, Inc.?

    The ticker symbol for ProPhase Labs, Inc. is NASDAQ:PRPH

    Does ProPhase Labs, Inc. pay dividends?

    No, ProPhase Labs, Inc. does not pay dividends

    What sector is ProPhase Labs, Inc. in?

    ProPhase Labs, Inc. is in the Healthcare sector

    What industry is ProPhase Labs, Inc. in?

    ProPhase Labs, Inc. is in the Diagnostics & Research industry

    What country is ProPhase Labs, Inc. based in?

    ProPhase Labs, Inc. is headquartered in United States

    When did ProPhase Labs, Inc. go public?

    ProPhase Labs, Inc.'s initial public offering (IPO) was on April 4, 1994

    Is ProPhase Labs, Inc. in the S&P 500?

    No, ProPhase Labs, Inc. is not included in the S&P 500 index

    Is ProPhase Labs, Inc. in the NASDAQ 100?

    No, ProPhase Labs, Inc. is not included in the NASDAQ 100 index

    Is ProPhase Labs, Inc. in the Dow Jones?

    No, ProPhase Labs, Inc. is not included in the Dow Jones index

    When was ProPhase Labs, Inc.'s last earnings report?

    ProPhase Labs, Inc.'s most recent earnings report was on November 19, 2025

    When does ProPhase Labs, Inc. report earnings?

    The next expected earnings date for ProPhase Labs, Inc. is March 30, 2026
    On this page